Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Publication year range
1.
Anaerobe ; 72: 102461, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34626800

ABSTRACT

Peptostreptococcus anaerobius is a gram-positive anaerobic coccus (GPAC) found in the gastrointestinal and vaginal microbiota. The organism is mainly found in polymicrobial and scarcely in monobacterial infections such as prosthetic and native endocarditis. Anaerobic bacteria have rarely been reported as the cause of urinary tract infection (UTI). Although GPAC are susceptible to most antimicrobials used against anaerobic infections, P. anaerobius has shown to be more resistant. Herein, we report a case of UTI caused by P. anaerobius from a 62-year-old man with a history of urological disease. Surprisingly, the microorganism was directly identified by Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) from the urine sample. The isolate was successfully identified by phenotypic methods, MALDI-TOF MS, and 16S rRNA gene sequencing. P. anaerobius showed no ß-lactamase-producing activity, was resistant to penicillin, ampicillin, ciprofloxacin and levofloxacin, and displayed intermediate susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid. Successful treatment was achieved with oral amoxicillin-clavulanic acid. Antimicrobial susceptibility testing (AST) should be performed on P. anaerobius isolates due to their unpredictable AST patterns and because empirically administered antimicrobial agents may not be active. This report shows that MALDI-TOF MS, directly used in urine specimens, may be a quick option to diagnose UTI caused by P. anaerobius or other anaerobic bacteria. This review is a compilation of monobacterial infections caused by P. anaerobius published in the literature, their pathogenicity, identification, and data about the antimicrobial susceptibility of P. anaerobius.


Subject(s)
Gram-Positive Bacterial Infections/microbiology , Peptostreptococcus/classification , Peptostreptococcus/physiology , Urinary Tract Infections/microbiology , Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Bacterial Typing Techniques , Disease Susceptibility , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/drug therapy , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Molecular Typing , Peptostreptococcus/drug effects , Peptostreptococcus/isolation & purification , RNA, Ribosomal, 16S/genetics , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Treatment Outcome , Urinary Tract Infections/diagnosis , Urinary Tract Infections/drug therapy
2.
Rev Neurol ; 69(4): 152-158, 2019 Aug 16.
Article in Spanish | MEDLINE | ID: mdl-31334558

ABSTRACT

AIM: To analyse the clinical findings, complementary examinations and prognosis of patients with progressive multifocal leukoencephalopathy (PML) treated in our institution, comparing populations with and without associated human immunodeficiency virus (HIV). PATIENTS AND METHODS: A retrospective study of the medical records of patients with probable or definite PML was carried out. Clinical variables, complementary studies (cerebrospinal fluid, magnetic resonance imaging of the brain) and prognostic variables were analysed. Non-parametric statistical tests were used to compare HIV-positive and HIV non-positive populations. RESULTS: Fourteen patients with definite and one probable diagnosis of PML were included. Nine patients had PML associated with HIV; five had other immunosuppressive conditions (two, chronic lymphatic leukaemia; one, multiple sclerosis; one, neuromyelitis optica; and one, neurosarcoidosis); and one, no obvious immunosuppressive condition. The population with HIV presented heterogeneous dirty-appearing white matter lesions more frequently (77.7% versus 16.67%; p = 0.0247) in the cerebral MRI. No other significant differences were identified in the remaining variables analysed. CONCLUSION: HIV/AIDS is the pathology most frequently associated with PML. With the use of immunomodulator drugs its appearance is reported in a variety of other diseases. Heterogeneous dirty-appearing white matter lesions were significantly more common in HIV patients.


TITLE: Espectro clinico de la leucoencefalopatia multifocal progresiva: diferencias y similitudes en pacientes con y sin virus de la inmunodeficiencia humana.Objetivo. Analizar los hallazgos clinicos, examenes complementarios y pronostico de los pacientes con leucoencefalopatia multifocal progresiva (LMP) atendidos en nuestra institucion, comparando las poblaciones con y sin virus de la inmunodeficiencia humana (VIH) asociado. Pacientes y metodos. Estudio retrospectivo de historias clinicas de pacientes con LMP probable o definitiva. Se analizaron variables clinicas, estudios complementarios (liquido cefalorraquideo, resonancia magnetica cerebral) y variables pronosticas. Mediante pruebas estadisticas no parametricas se realizo la comparacion entre las poblaciones con y sin VIH. Resultados. Se incluyo a 14 pacientes con diagnostico de LMP definitiva y uno probable. Nueve pacientes presentaron LMP asociada a VIH; cinco, otras condiciones de inmunoafectacion (dos, leucemia linfatica cronica; uno, esclerosis multiple; uno, neuromielitis optica; y uno, neurosarcoidosis); y uno, sin condicion inmunosupresora evidente. La poblacion con VIH presento con mayor frecuencia lesiones de la sustancia blanca heterogeneas de aspecto «sucio¼ (77,7% frente a 16,67%; p = 0,0247) en la resonancia magnetica cerebral. No se identificaron otras diferencias significativas en las restantes variables analizadas. Conclusion. El VIH/sida es la patologia mas frecuente asociada a LMP. Con el uso de farmacos inmunomoduladores se describe su aparicion en una variedad de otras enfermedades. Las lesiones de la sustancia blanca heterogeneas de aspecto «sucio¼ fueron significativamente mas frecuentes en pacientes con VIH.


Subject(s)
HIV Infections/complications , Leukoencephalopathy, Progressive Multifocal/complications , Adult , Aged , Cerebrospinal Fluid/virology , Female , Humans , Immunocompromised Host , Immunologic Factors/therapeutic use , JC Virus/physiology , Leukoencephalopathy, Progressive Multifocal/diagnostic imaging , Leukoencephalopathy, Progressive Multifocal/pathology , Leukoencephalopathy, Progressive Multifocal/virology , Magnetic Resonance Imaging , Male , Middle Aged , Neuroimaging , Retrospective Studies , Virus Activation , White Matter/diagnostic imaging , White Matter/pathology
3.
Anaerobe ; 59: 176-183, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31254654

ABSTRACT

Cutibacterium avidum is a gram-positive anaerobic rod belonging to the cutaneous group of human bacteria with preferential colonization of sweat glands in moist areas. The microorganism rarely cause disease, generally delayed prosthetic joint infections (PJIs). We describe the second case of intraperitoneal abscess by C. avidum after an abdominal surgery in an obese female patient and the first case after a non-prosthetic abdominal surgery due to a highly clindamycin resistant strain in a patient with underling conditions. The patient was successfully treated with surgical drainage and beta-lactam antibiotics. Although rare and apparently non-pathogenic, C. avidum may be involved in infections, especially in some high-risk patients with obesity who have undergone surgical incision involving deep folder of the skin. The microorganism was identified by phenotypic methods, MALDI-TOF MS and 16S rRNA gene sequencing. Susceptibility test should be performed in C. avidum because high level resistance to clindamycin could be present. We present a literature review of C. avidum infections.


Subject(s)
Abdominal Abscess/diagnosis , Abdominal Abscess/pathology , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/pathology , Hysterectomy/adverse effects , Laparotomy/adverse effects , Propionibacteriaceae/isolation & purification , Abdominal Abscess/microbiology , Anti-Bacterial Agents/pharmacology , Clindamycin/pharmacology , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Drug Resistance, Bacterial , Gram-Positive Bacterial Infections/microbiology , Humans , Hysterectomy/methods , Laparotomy/methods , Obesity/complications , Propionibacteriaceae/classification , Propionibacteriaceae/drug effects , Propionibacteriaceae/genetics , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA
4.
Clin Endocrinol (Oxf) ; 17(1): 15-9, 1982 Jul 01.
Article in English | MEDLINE | ID: mdl-7116653

ABSTRACT

We have tested the hypothesis that physiological puerperal hyperprolactinaemia may be secondary to reduced hypothalamic dopaminergic inhibition of prolactin (PRL) release. Nine post-partum females with physiological hyperprolactinaemia (aged 19-40 years; mean basal PRL +/- SE, 2099 +/- 257 mU/1, range 1002-3762 mU/1) were studied and results compared with fourteen normoprolactinaemic females (basal PRL less than 400 mU/1; aged 18-36 years). Puerperal hyperprolactinaemic females showed a reduced TSH response to dopamine (DA) receptor blockade with metoclopramide (10 mg i.v.) compared with normal females over a 60-min period following drug administration (total incremental TSH change, mean +/- SE, mU/1; 0.5 +/- 0.3 v. 3.1 +/- 1.0 P less than 0.005). This finding of reduced dopaminergic inhibition of TSH release in females with physiological puerperal hyperprolactinaemia supports the view that an overall reduction in hypothalamic dopaminergic tone may contribute towards hyperprolactinaemia in post-partum women.


Subject(s)
Metoclopramide/pharmacology , Postpartum Period , Prolactin/blood , Thyroid Gland/drug effects , Thyrotropin/metabolism , Adult , Female , Humans , Hypothalamus/drug effects , Pregnancy , Thyroid Gland/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL